Tech Company Financing Transactions

Concert Pharmaceuticals Funding Round

On 11/30/2006, Concert Pharmaceuticals raised $48.5 million in Series B financing from Flagship Pioneering, Greylock Partners and New Leaf Venture Partners.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

99 Hayden Ave. 500
Lexington, MA 02421
USA

Phone

(781) 860-0045

Website

www.concertpharma.com

Email Address

[email protected]

Overview

Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform to create novel small molecule drugs.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Roger Tung

        

Chief Financial Officer

Marc Becker

        

Chief Operating Officer

Nancy Stuart

        

VP - Bus. Development

James Cassella

        

Browse more venture capital transactions:

Prev: 11/30/2006: ITN Networks venture capital transaction
Next: 11/30/2006: Renovar venture capital transaction

Share this article

Where The Data Comes From

We do our best to record tech company VC transactions. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary